Location: New Jersey, USA.
Department affected: cell therapy vector production.
Based on news reporting.
Bristol-Myers Squibb Company has announced a reduction in its workforce, affecting approximately 300 employees as part of a restructuring effort. This decision comes amid ongoing challenges in the pharmaceutical industry, with the company aiming to streamline operations and improve efficiency. The layoffs are expected to take effect immediately, impacting various departments within the organization. The company has indicated that these changes are necessary to better align with its strategic goals and respond to market demands. This move reflects a broader trend in the industry as companies adjust to economic pressures and changing market conditions.
Bristol-Myers Squibb Company cut 300 jobs affecting its cell therapy vector production team as of October 1, 2023.
That is roughly 0.9% of the 34,100 people Bristol-Myers Squibb Company employs.
LayoffTalk has tracked 27 layoff events at Bristol-Myers Squibb Company since October 2023, affecting a combined 7,522 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
Bristol-Myers Squibb Company cut 300 jobs on October 1, 2023. If you were part of this round, what was your experience? Others going through it are reading. You can post anonymously below.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.